Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 1656Skin Neoplasms 355Lymphoma, T-Cell, Cutaneous 322Carcinoma, Basal Cell 241Mycosis Fungoides 227Sezary Syndrome 209Breast Neoplasms 196Leukemia, Lymphocytic, Chronic, B-Cell 193Lymphoma, Non-Hodgkin 192Lymphoma, Follicular 187Precursor Cell Lymphoblastic Leukemia-Lymphoma 183Lymphoma, Large B-Cell, Diffuse 183Lymphoma, B-Cell, Marginal Zone 182Lymphoma, Mantle-Cell 181Hodgkin Disease 175Lymphoma 174Burkitt Lymphoma 173Uveal Melanoma 170Lymphoma, Large-Cell, Immunoblastic 168Multiple Myeloma 159Keratosis, Actinic 146Neoplasms 142Leukemia, Myeloid, Acute 134Neoplasm Metastasis 125Lymphoma, Large-Cell, Anaplastic 125Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 123Lung Neoplasms 120Immunoblastic Lymphadenopathy 115Leukemia, Myeloid, Accelerated Phase 113Leukemia, Myeloid, Chronic-Phase 112

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Advanced Melanoma × Dermatologic × Clear all
NCT05869539 2026-02-27

BaseTIL-03M

University Hospital, Basel, Switzerland

Phase 1 Active not recruiting
10 enrolled
Dermatologic

Advanced Melanoma

NCT03818893 2019-01-30

Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII

Osaka University

Phase 2 Unknown
46 enrolled
Dermatologic

Advanced Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡